About
Aethlon Medical Inc (NASDAQ:AEMD) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 24 2026
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
Mar 18 2026
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, CEO and CFO of Aethlon Medical, and M. Marin, Senior Analyst at Zacks SCR
Mar 13 2026
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Mar 12 2026
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
Mar 10 2026
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
Financials
Revenue
$574.25 K
Market Cap
$3.34 M
EPS
-48.46
Translate